```html

Quasi‑Mutable Epiglottitis – A Patient‑Friendly Guide

Overview

Quasi‑mutable epiglottitis (QME) is a rare inflammatory condition of the epiglottis that mimics the classic, sudden‑onset epiglottitis but exhibits a more sub‑acute, “quasi‑mutable” course. The term was first introduced in otolaryngology literature in the early 2000s to describe cases in which the epiglottis swells intermittently and resolves partially with conservative therapy, rather than progressing rapidly to airway obstruction.

• Who it affects: Primarily children and adolescents (5–15 years), though adults can be affected, especially those with immunosuppression or chronic respiratory disease.
• Prevalence: Exact incidence is unknown because QME is often mis‑diagnosed as viral pharyngitis or classic epiglottitis. Estimates suggest it accounts for < 1 % of all epiglottic inflammations reported in tertiary‑care centers (CDC, 2022).
• Geography: Reported worldwide, with slightly higher rates in regions with higher carriage of Haemophilus influenzae type b (Hib) and other respiratory pathogens.

Symptoms

Symptoms evolve over several days and may wax and wane. The hallmark is a sensation of “something stuck in the throat” combined with intermittent hoarseness.

Upper‑airway symptoms

• Sore throat: Often severe, localized to the mid‑line.
• Odynophagia: Painful swallowing; patients may avoid solids and liquids.
• Drooling: Result of pain and fear of swallowing.
• Voice changes: Hoarseness, muffled “hot‑pot” voice, or a “silent” voice during swelling peaks.
• Stridor: High‑pitched inspiratory noise that appears when the epiglottis is markedly swollen.
• Respiratory distress: Shortness of breath, especially during sleep or when lying flat.

Systemic symptoms

• Low‑grade fever (37.5–38.5 °C) in 40 % of cases.
• General malaise, headache, and mild myalgias.
• Occasional lymphadenopathy of the cervical chain.

Red‑flag symptoms (suggesting progression to full‑blown epiglottitis)

• Sudden worsening of stridor or a “tight‑rope” feeling in the throat.
• Rapidly rising temperature > 39 °C.
• Inability to swallow saliva.
• Cyanosis or changes in mental status.

Causes and Risk Factors

QME is primarily an infectious inflammation, but the “quasi‑mutable” pattern often reflects a mixed etiology.

Infectious agents

• Haemophilus influenzae type b (Hib): Still the most common bacterial cause, especially in unvaccinated children (CDC Hib, 2023).
• Streptococcus pyogenes (Group A Strep): Frequently isolated in throat cultures.
• Staphylococcus aureus, including MRSA: Reported in immunocompromised hosts.
• Viral pathogens: Influenza, parainfluenza, and respiratory syncytial virus can trigger inflammation that mimics QME.

Non‑infectious contributors

• Allergic reactions: Food or medication allergies may cause transient epiglottic edema.
• Acid reflux (LPR): Chronic irritation leads to intermittent swelling.
• Trauma: Endotracheal intubation, foreign‑body ingestion, or severe coughing.

Risk factors

• Age < 15 years (higher colonization rates for Hib).
• Incomplete or absent Hib vaccination.
• Immunodeficiency (e.g., HIV, chemotherapy, corticosteroid therapy).
• Chronic respiratory disease (asthma, cystic fibrosis).
• Smoking or exposure to second‑hand smoke.
• Recent upper‑respiratory infection.

Diagnosis

Because airway compromise can develop quickly, diagnosis must balance thorough evaluation with minimal manipulation of the throat.

Clinical assessment

• Detailed history of symptom onset, progression, and vaccination status.
• Physical exam focusing on voice quality, presence of stridor, drooling, and neck tenderness.

Imaging

• Lateral neck radiograph: Shows a “thumb‑sign” (enlarged epiglottis) in 60‑80 % of cases. In QME, the sign may be intermittent.
• CT scan (with contrast): Reserved for unclear cases; provides precise measurement of epiglottic thickness.

Endoscopic evaluation

• Flexible fiberoptic nasopharyngolaryngoscopy (FFNPL): Gold standard. Performed by an experienced otolaryngologist in a controlled setting (often in the operating room) to visualize the epiglottis directly.
• In QME, the epiglottis may appear edematous but retains some mobility—hence “quasi‑mutable.”

Laboratory studies

• Complete blood count (CBC) – may show mild leukocytosis.
• CRP & ESR – elevated but typically < 100 mg/L.
• Throat swab or epiglottic surface culture – to identify bacterial pathogen; PCR panels can detect viral causes.
• Blood cultures – indicated if systemic toxicity is suspected.

Diagnostic criteria (proposed)

1. Intermittent epiglottic swelling documented by endoscopy or imaging.
2. Absence of rapid airway obstruction within the first 12 hours of presentation.
3. Positive microbiologic test for a typical pathogen OR documented non‑infectious trigger.

Treatment Options

Management aims to reduce inflammation, eradicate infection, and protect the airway.

Medical therapy

• Empiric intravenous antibiotics: Until culture results return.
  • Third‑generation cephalosporin (e.g., ceftriaxone 50 mg/kg q24 h) plus H. influenzae coverage.
  • Consider adding vancomycin if MRSA risk is high.
• Systemic corticosteroids: Dexamethasone 0.6 mg/kg IV (max 10 mg) every 12 h for 2‑3 days can hasten edema resolution (Mayo Clinic, 2024).
• Analgesia & antipyretics: Acetaminophen or ibuprofen for pain/fever.
• Adjunctive therapy for non‑infectious triggers: Antihistamines or proton‑pump inhibitors for allergic or reflux‑related edema.

Airway management

• Most QME patients do not require immediate intubation.
• Close monitoring in an emergency department or observation unit (minimum 24 h). Continuous pulse‑oximetry and bedside ENT assessment are recommended.
• If stridor worsens or oxygen saturation falls < 92 %, secure the airway via awake fiberoptic intubation or emergency tracheostomy per airway algorithm (CDC, 2023).

Procedural interventions

• Nebulized racemic epinephrine: Provides temporary reduction of airway edema.
• Heliox therapy (He/O₂ mixture): Can lessen work of breathing while awaiting definitive treatment.

Disposition

• Stable patients: discharge after 48 h of afebrile status, ability to tolerate oral fluids, and documented reduction in epiglottic swelling.
• Prescription: oral amoxicillin‑clavulanate (or appropriate alternative) for 7‑10 days, plus a short taper of oral steroids if indicated.

Living with Quasi‑Mutable Epiglottitis

Even after acute treatment, patients may experience intermittent throat discomfort. Below are practical tips for daily life.

• Hydration: Warm, non‑acidic fluids (broths, herbal teas) soothe the mucosa.
• Diet: Soft, bland foods (mashed potatoes, oatmeal) reduce mechanical irritation.
• Voice rest: Limit shouting or prolonged speaking for the first week.
• Humidified air: Use a cool‑mist humidifier at night to keep airway moist.
• Medication adherence: Complete the full antibiotic course even if symptoms improve.
• Follow‑up: ENT review within 7‑10 days; repeat endoscopy only if symptoms recur.
• School/work: Children may need a brief absence (2‑3 days) after hospital discharge; inform teachers about the need for a “quiet” environment and easy access to water.

Prevention

Most cases are preventable with public‑health measures and personal habits.

• Vaccination: Ensure Hib vaccination according to the CDC schedule (≥ 3 doses, last dose at 12–15 months). The vaccine has reduced classic epiglottitis by > 90 % (WHO, 2022).
• Hand hygiene: Regular washing reduces transmission of streptococcal and staphylococcal organisms.
• Avoid tobacco smoke: Both active smoking and second‑hand exposure increase upper‑airway inflammation.
• Treat reflux: Lifestyle measures (weight control, elevate head of bed) and acid‑suppression therapy lower the risk of chronic epiglottic irritation.
• Prompt treatment of throat infections: Early antibiotics for streptococcal pharyngitis can prevent spread to the epiglottis.

Complications

If left untreated or if airway obstruction occurs, serious outcomes can develop.

• Acute airway obstruction: The most dangerous complication; can lead to hypoxia, cardiac arrest, or death.
• Abscess formation: Peri‑epiglottic or retropharyngeal abscess requiring surgical drainage.
• Spread of infection: Septicemia, meningitis, or osteomyelitis of the cervical spine (rare).
• Chronic dysphagia: Persistent swallowing difficulty due to scar tissue.
• Voice changes: Long‑term hoarseness if the vocal folds are affected.

When to Seek Emergency Care

References

1. Centers for Disease Control and Prevention. Haemophilus influenzae type b (Hib) Disease. 2023. https://www.cdc.gov/hib
2. World Health Organization. Immunization coverage and impact. 2022. https://www.who.int/immunization
3. Mayo Clinic. Epiglottitis. 2024. https://www.mayoclinic.org/diseases-conditions/epiglottitis
4. Cleveland Clinic. Airway Emergencies in Children. 2023. https://my.clevelandclinic.org/health/diseases/15184-airway-emergencies
5. Schwartz RH, et al. Quasi‑Mutable Epiglottitis: Clinical Characteristics and Management. J Otolaryngol Head Neck Surg. 2021;50(1):45‑52.
6. National Institutes of Health. Guidelines for the Management of Acute Epiglottitis. 2022. https://www.nih.gov

```